Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 11,350
-390 (-3.32%)
At close: Jul 6, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 172.27 billion as of July 7, 2026. Its market cap has increased by 23.78% in one year.
Market Cap
172.27B
Enterprise Value
146.73B
Revenue
2.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,350.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 172.27B, a decrease of -2.94%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 172.27B | -50.44% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 257.71B |
| S.Biomedics | 254.51B |
| curacle co.,ltd. | 247.13B |
| NIBEC | 193.14B |
| Kanaph Therapeutics | 182.52B |
| Ensol Biosciences | 177.32B |
| Genome & Company | 169.87B |
| Prestige Biologics | 154.73B |